Dear USET/USET SPF Family,
As part of their settlement agreement under the opioid litigation, the drug company Teva has agreed to provide Tribal Nations with up to 400,000 doses of Naloxone Hydrochloride Nasal Spray (the generic version of Narcan), which is used in the emergency treatment of opioid overdoses. Teva will provide up to 20,000 Naloxone boxes per year for 10 years, with two doses in each both. Tribal Nations are eligible to request these boxes for free.
Each Tribal Nation is entitled to a certain share of the Naloxone, and the allocation is based on the "Purdue Allocation." Tribal Nations may find their share on the chart available on the litigation management portal. The Naloxone maybe distributed by Tribal Nations as they see fit.
To receive a share of the Naloxone, Tribal Nations must fill out the Naloxone Interest Form on the litigation management portal by October 15, 2023. If a Tribal Nation does not request the Naloxone by the deadline, its share will be made available to to other interested Tribal Nations.
For more information, please contact Ashton Martin, USET SPF Health Policy Analyst, at email@example.com.